Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vieth

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 14, 2008
Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's databaseB H A von Rahden, H J Stein, A Weber, et al.
Endoscopy|May 28, 2010
Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagusM Bajbouj, M Vieth, T Rösch, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2011
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD studyP Malfertheiner, M Nocon, M Vieth, et al.
Gut|May 8, 2008
Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagusO Pech, A Behrens, A May, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2006
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD studyD Jaspersen, J Labenz, S N Willich, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD StudyD Jaspersen, M Kulig, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiativeM Kulig, A Leodolter, M Vieth, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
Radial distribution of dilated intercellular spaces of the esophageal squamous epithelium in patients with reflux disease exhibiting discrete endoscopic lesionsM Vieth, R Fiocca, J Haringsma, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistanceS Miehlke, W Schneider-Brachert, E Bästlein, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 14, 2008
Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's databaseB H A von Rahden, H J Stein, A Weber, et al.
Endoscopy|May 28, 2010
Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagusM Bajbouj, M Vieth, T Rösch, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2011
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD studyP Malfertheiner, M Nocon, M Vieth, et al.
Gut|May 8, 2008
Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagusO Pech, A Behrens, A May, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 18, 2006
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD studyD Jaspersen, J Labenz, S N Willich, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD StudyD Jaspersen, M Kulig, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiativeM Kulig, A Leodolter, M Vieth, et al.
Digestive Diseases (Basel, Switzerland)|September 24, 2004
Radial distribution of dilated intercellular spaces of the esophageal squamous epithelium in patients with reflux disease exhibiting discrete endoscopic lesionsM Vieth, R Fiocca, J Haringsma, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistanceS Miehlke, W Schneider-Brachert, E Bästlein, et al.
Pageof 20